Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 known ✓ | P36888 | 1/20 | 0.38 |
| ▸ | CRBN known ✓ | Q96SW2 | 1/20 | 0.36 |
| ▸ | CCR2 | P41597 | 6/20 | 0.41 |
| ▸ | MERTK | Q12866 | 9/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | AXL | P30530 | 1/20 | 0.38 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3374187 | 1.00 | CCR2 (0.41) | CCR2MERTKHTTAXLFLT3 | |
| Hydrochloric Acid SCHEMBL1114699 | 1.00 | CCR2 (0.41) | CCR2MERTKHTTAXLFLT3 | |
| SCHEMBL56745 | 0.98 | — | — | |
| SCHEMBL1114446 | 0.98 | — | — | |
| SCHEMBL1927815 | 0.98 | — | — | |
| SCHEMBL15132456 | 0.95 | CCR2 (0.44) | CCR2MERTKHTTAXLFLT3 | |
| Hydrochloric Acid SCHEMBL11818708 | 0.95 | CCR2 (0.41) | CCR2MERTKHTTAXLFLT3 | |
| SCHEMBL11819356 | 0.95 | CCR2 (0.41) | CCR2MERTKHTTAXLFLT3 | |
| SCHEMBL6978411 | 0.95 | CCR2 (0.44) | CCR2MERTKHTTAXLFLT3 | |
| SCHEMBL6202076 | 0.95 | CCR2 (0.44) | CCR2MERTKHTTAXLFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117658917-A | Preparation method of dimethylaminocaprolactam and application thereof, and cleaning/sterilizing material | 中国石油化工股份有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-117288849-A | Method for detecting L-lysine and alpha-amino epsilon-caprolactam in lysine injection solvent | 浙江普洛家园药业有限公司 | 2023-12-26 | — | — | CN | claimed |
| WO-2021210920-A1 | METHOD FOR PRODUCING RAMELTEON, AND INTERMEDIATE COMPOUND USED FOR SAME | 제이투에이치바이오텍 주식회사 | 2021-10-21 | — | — | WO | claimed |
| US-3988320-A | CRYSTALLIZATION OF AN ALPHA-AMINO-EPSILON-CAPROLACTAM-NICKEL CHLORIDE COMPLEX | ALLIED CHEMICAL CORPORATION (US) | 1976-10-26 | — | — | US | claimed |
| US-3931308-A | Process for conversion of lysine dihydrochloride to lysine monohydrochloride | ALLIED CHEMICAL CORPORATION (US) | 1976-01-06 | — | — | US | claimed |
| EP-4612140-A1 | NEK7 DEGRADERS AND METHODS OF USE THEREOF | Captor Therapeutics S.A. (PL) | 2025-09-10 | — | — | EP | disclosed |
| WO-2025136129-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET PROTEIN KINASE C | CAPTOR THERAPEUTICS S.A. (PL) | 2025-06-26 | — | — | WO | disclosed |
| EP-3813834-B1 | NEW CRBN MODULATORS | DANA FARBER CANCER INST INC (US) | 2025-03-26 | — | — | EP | disclosed |
| CN-119638979-A | Antibacterial nylon material and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2025-03-18 | — | — | CN | disclosed |
| CN-119306663-A | Continuous production method and system for lactam monomer | 中国石油化工股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-118807655-A | Method and reaction system for continuously producing lactam monomer | 中国石油化工股份有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118812432-A | Continuous production method and system of lactam monomer | 中国石油化工股份有限公司 | 2024-10-22 | — | — | CN | disclosed |
| WO-2002064551-A1 | HIV PROTEASE INHIBITORS BASED ON AMINO ACID DERIVATIVES | PHARMACOR INC. (CA) | 2002-08-22 | — | — | WO | disclosed |
| EP-1227083-A1 | 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS | MEIJI SEIKA KAISHA LTD. (JP) | 2002-07-31 | — | — | EP | disclosed |
| EP-0083332-A2 | Asymmetric reduction of nitro-containing prochiral compounds | MONSANTO COMPANY (US) | 1983-07-06 | — | — | EP | disclosed |
| US-4154956-A | REACTING A-AMINO-E-CAPROLACTAM WITH AN ALCOHOL AND AN ACID CATALYST, SALT FORMATION, DECYCLIZATION, ESTERIFICATION | TORAY INDUSTRIES, INC. (JP) | 1979-05-15 | — | — | US | disclosed |
| US-3988320-A | CRYSTALLIZATION OF AN ALPHA-AMINO-EPSILON-CAPROLACTAM-NICKEL CHLORIDE COMPLEX | ALLIED CHEMICAL CORPORATION (US) | 1976-10-26 | — | — | US | disclosed |
| US-3988320-A | CRYSTALLIZATION OF AN ALPHA-AMINO-EPSILON-CAPROLACTAM-NICKEL CHLORIDE COMPLEX | ALLIED CHEMICAL CORPORATION (US) | 1976-10-26 | — | — | US | disclosed |
| US-3941776-A | RACEMIZATION OF AMINOLACTAM COMPOUNDS | ALLIED CHEMICAL CORPORATION (US) | 1976-03-02 | — | — | US | disclosed |
| US-3931308-A | Process for conversion of lysine dihydrochloride to lysine monohydrochloride | ALLIED CHEMICAL CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |